Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 2
1989 2
1990 2
1991 4
1992 3
1993 5
1994 4
1995 3
1996 2
1997 2
1998 2
1999 5
2000 4
2001 1
2002 6
2003 8
2004 10
2005 6
2006 5
2007 6
2008 12
2009 14
2010 16
2011 17
2012 14
2013 12
2014 9
2015 9
2016 6
2017 12
2018 8
2019 6
2020 10
2021 5
2022 8
2023 13
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

223 results

Results by year

Filters applied: . Clear all
Page 1
A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments.
Stirnemann J, Belmatoug N, Camou F, Serratrice C, Froissart R, Caillaud C, Levade T, Astudillo L, Serratrice J, Brassier A, Rose C, Billette de Villemeur T, Berger MG. Stirnemann J, et al. Among authors: caillaud c. Int J Mol Sci. 2017 Feb 17;18(2):441. doi: 10.3390/ijms18020441. Int J Mol Sci. 2017. PMID: 28218669 Free PMC article. Review.
Neuronal ceroid lipofuscinoses.
Chabrol B, Caillaud C, Minassian B. Chabrol B, et al. Among authors: caillaud c. Handb Clin Neurol. 2013;113:1701-6. doi: 10.1016/B978-0-444-59565-2.00038-1. Handb Clin Neurol. 2013. PMID: 23622391 Review.
Research priorities for COVID-19 sensor technology.
Tong A, Sorrell TC, Black AJ, Caillaud C, Chrzanowski W, Li E, Martinez-Martin D, McEwan A, Wang R, Motion A, Bedoya AC, Huang J, Azizi L, Eggleton BJ; COVID-19 Sensor Research Priority-Setting Investigators. Tong A, et al. Among authors: caillaud c. Nat Biotechnol. 2021 Feb;39(2):144-147. doi: 10.1038/s41587-021-00816-8. Nat Biotechnol. 2021. PMID: 33462510 No abstract available.
Gene therapy in lysosomal diseases.
Caillaud C, Poenaru L. Caillaud C, et al. Biomed Pharmacother. 2000 Oct;54(10):505-12. doi: 10.1016/s0753-3322(00)00009-3. Biomed Pharmacother. 2000. PMID: 11130848 Review.
Beta2-agonists and exercise-induced asthma.
Anderson SD, Caillaud C, Brannan JD. Anderson SD, et al. Among authors: caillaud c. Clin Rev Allergy Immunol. 2006 Oct-Dec;31(2-3):163-80. doi: 10.1385/CRIAI:31:2:163. Clin Rev Allergy Immunol. 2006. PMID: 17085791 Review.
'Clinical trials in Alzheimer's disease': immunotherapy approaches.
Delrieu J, Ousset PJ, Caillaud C, Vellas B. Delrieu J, et al. Among authors: caillaud c. J Neurochem. 2012 Jan;120 Suppl 1:186-193. doi: 10.1111/j.1471-4159.2011.07458.x. Epub 2011 Nov 28. J Neurochem. 2012. PMID: 21883222 Free article. Retracted. Review.
New insights into therapeutic options for Pompe disease.
Richard E, Douillard-Guilloux G, Caillaud C. Richard E, et al. Among authors: caillaud c. IUBMB Life. 2011 Nov;63(11):979-86. doi: 10.1002/iub.529. Epub 2011 Oct 14. IUBMB Life. 2011. PMID: 22002928 Free article. Review.
223 results